259 related articles for article (PubMed ID: 22184096)
1. Coincubation of PON1, APO A1, and LCAT increases the time HDL is able to prevent LDL oxidation.
Hine D; Mackness B; Mackness M
IUBMB Life; 2012 Feb; 64(2):157-61. PubMed ID: 22184096
[TBL] [Abstract][Full Text] [Related]
2. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
3. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
Vohl MC; Neville TA; Kumarathasan R; Braschi S; Sparks DL
Biochemistry; 1999 May; 38(19):5976-81. PubMed ID: 10320323
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
5. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
Nguyen SD; Sok DE
Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
[TBL] [Abstract][Full Text] [Related]
7. A dual role for lecithin:cholesterol acyltransferase (EC 2.3.1.43) in lipoprotein oxidation.
McPherson PA; Young IS; McEneny J
Free Radic Biol Med; 2007 Dec; 43(11):1484-93. PubMed ID: 17964419
[TBL] [Abstract][Full Text] [Related]
8. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
Nguyen SD; Sok DE
Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
[TBL] [Abstract][Full Text] [Related]
9. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity.
Bielicki JK; Forte TM; McCall MR
J Lipid Res; 1996 May; 37(5):1012-21. PubMed ID: 8725153
[TBL] [Abstract][Full Text] [Related]
10. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
11. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
[TBL] [Abstract][Full Text] [Related]
12. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Moradi H; Pahl MV; Elahimehr R; Vaziri ND
Transl Res; 2009 Feb; 153(2):77-85. PubMed ID: 19138652
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
Tsujita M; Yokoyama S
Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
[TBL] [Abstract][Full Text] [Related]
15. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase.
Itabe H; Hosoya R; Karasawa K; Jimi S; Saku K; Takebayashi S; Imanaka T; Takano T
J Biochem; 1999 Jul; 126(1):153-61. PubMed ID: 10393333
[TBL] [Abstract][Full Text] [Related]
17. Lecithin/cholesterol acyltransferase induces estradiol esterification in high-density lipoprotein, increasing its antioxidant potential.
Höckerstedt A; Jauhiainen M; Tikkanen MJ
J Clin Endocrinol Metab; 2004 Oct; 89(10):5088-93. PubMed ID: 15472210
[TBL] [Abstract][Full Text] [Related]
18. Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins.
Kosek AB; Durbin D; Jonas A
Biochem Biophys Res Commun; 1999 May; 258(3):548-51. PubMed ID: 10329423
[TBL] [Abstract][Full Text] [Related]
19. The antioxidant properties of high-density lipoproteins in atherosclerosis.
Mackness B; Mackness M
Panminerva Med; 2012 Jun; 54(2):83-90. PubMed ID: 22525563
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
Li C; Gu Q
Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
